FTC Extends Scrutiny Of MDS' $650M Sale To Danaher

By Samuel Howard

Law360, New York (November 03, 2009, 3:26 PM ET) -- Antitrust officials scrutinizing Danaher Corp.’s proposed acquisition of MDS Inc.’s analytical technologies unit have extended their review of the $650 million cash transaction.

On Tuesday, MDS announced that the U.S. Federal Trade Commission sent the life sciences company a second request for information about the slated deal, suggesting regulatory concerns about Danaher’s expansion further into the life sciences instrumentation market.

MDS said the request relates to a global market segment that generates less than $50 million in annual revenue for all sellers, but provided no further...
To view the full article, take a free trial now.

Already a subscriber? Click here to login

You must correct or enter the following before you can submit this form:

All fields required

  5. Required

Only Law360 gives you:

Non-stop coverage of high-stakes litigation across 30 practices

Real-time tracking and reports on 10,000+ companies, firms and industries

Over 80,000 attorney profiles with neutral data collected from active lawsuits

Research tools to find cases, court documents, attorneys and companies

Customized feeds and alerts that can easily be shared with colleagues

In-depth expert analysis from high-profile attorneys at top firms

Access to our vault with over 75,000 original articles